Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
More News related to AMED
- Amedisys (AMED) Releases Review Report from Marwood Group Advisory
- Amedisys Releases Report from Marwood Group Advisory
- Amedisys to Present at the Oppenheimer 20th Annual Healthcare Conference
- Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
- Amedisys (AMED) options active after reaffirming FY2009 guidance
Stifel Nicolaus upgrades Amedisys (Nasdaq: AMED) from Hold to Buy.
To see more analyst ratings on AMED Click Here.
Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population.
Related Categories
UpgradesStocks Mentioned
+0.21Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
